Updated Jul 16, 2026
Okey Stephanie has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.83M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | CRNX | Crinetics Pharmaceuticals, Inc. | A — Grant or award | 5.9K | $0.00 | |
| 2026-06-18 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale | 608 | $36.22 | $22K |
| 2026-06-18 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale | 6.3K | $35.62 | $224K |
| 2026-03-12 | PTCT | PTC THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 14.0K | $70.00 | $980K |
| 2026-03-12 | PTCT | PTC THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 14.0K | $33.63 | $471K |
| 2026-03-12 | PTCT | PTC THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 1.2K | $70.00 | $82K |
| 2026-03-12 | PTCT | PTC THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 1.2K | $33.63 | $39K |
| 2026-03-09 | PTCT | PTC THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 6.3K | $63.38 | $401K |
| 2026-03-04 | CRNX | Crinetics Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 3.0K | $39.67 | $119K |
| 2024-12-18 | CTLT | Catalent, Inc. | D — Derivative transaction | 12.6K | — | |
| 2024-11-01 | CTLT | Catalent, Inc. | A — Grant or award | 4.7K | $0.00 |
Okey Stephanie is a corporate insider — currently tracked as Director of Crinetics Pharmaceuticals, Inc. (CRNX). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($1.83M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Okey Stephanie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.